Cargando…
MED12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas
Uterine leiomyomas cause heavy menstrual bleeding, anemia, and pregnancy loss in millions of women worldwide. Driver mutations in the transcriptional mediator complex subunit 12 (MED12) gene in uterine myometrial cells initiate 70% of leiomyomas that grow in a progesterone-dependent manner. We showe...
Autores principales: | Zuberi, Azna, Huang, Yongchao, Dotts, Ariel J., Wei, Helen, Coon, John S., Liu, Shimeng, Iizuka, Takashi, Wu, Olivia, Sotos, Olivia, Saini, Priyanka, Chakravarti, Debabrata, Boyer, Thomas G., Dai, Yang, Bulun, Serdar E., Yin, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561729/ https://www.ncbi.nlm.nih.gov/pubmed/37607000 http://dx.doi.org/10.1172/jci.insight.171305 |
Ejemplares similares
-
THU625 Med12 Mutation Activates Tryptophan-Kynurenine-ahr Pathway To Promote Growth Of Uterine Leiomyoma
por: Zuberi, Azna, et al.
Publicado: (2023) -
Mono-(2-ethyl-5-hydroxyhexyl) phthalate promotes uterine leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation
por: Iizuka, Takashi, et al.
Publicado: (2022) -
Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status
por: Hutchinson, Anne P., et al.
Publicado: (2022) -
THU631 Steroyl-CoA Desaturase Is A Progesterone Receptor Target Gene In Uterine Leiomyoma
por: Komorowski, Allison S, et al.
Publicado: (2023) -
Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma
por: Liu, Shimeng, et al.
Publicado: (2018)